Cellular Therapy: Targets and Effectors.- Adoptive Immunotherapy in Chimeras.- The Roles of the Chemokine SDF-1 and its Receptor CXCR4 in Human Stem Cell Migration and Repopulation of NOD/SCID and B2mnull NOD/SCID mice.- Towards Adoptive Immunotherapy Using High Affinity T Cell Receptors.- New Antigens and Avenues to Immunotherapy of Cancer.- Allogeneic Cell Therapy with Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Malignant Melanoma.- New Conditioning Strategies n Allogeneic Stem Cell Transplantation.- Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an188 Re Labelled anti CD 66 Monoclonal Antibody.- Dose Reduced Conditioning for Allogeneic Blood Stem Cell Transplantation from Sibling and Unrelated Donors in 51 Patients.- Pharmacokinetics of Conditioning Regimens.- Megadose Stem Cell Transplantation.- HD-Ara-C in the Conditioning Regimen for BMT in Acute Leukemias.- TBI-Based Reduced Intensity Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation (SCT) in Patients with High-Risk Hematologic Malignancies.- Total Marrow Irradation (TMI), Busulfan, and Cyclophos-phamide for Allografting in Multiple Myeloma. A Pilot Study.- Stem Cell Mobilisation, Processing and Characteristics.- A Single Delayed Application of G-CSF after Autologous Peripheral Blood Stem Cell Transplantation A Pilot Study.- Factors Influencing PBPC Mobilisation and Collection in Haematological Malignancies.- Successful Purging of Stem Cell Products Using CD34 Selection.- Autologous Transplantation of Non-Cryopreserved HSCs in Oncologic Patients with Poor Prognosis: First Experience in the Ukraine.- A Randomized Comparison of Once Versus Twice Daily rhG-CSF (Filgrastim) for Stem Cell Mobilisation in Healthy Donors for Allogeneic Transplantation.- CD 133/CD34 Expression on Hematopoietic Stem-/ Progenitor Cells and Acute Leukemic Blasts.- Identification of Minimal Residual Leukemia Applying Continuous Gating.- Corl1